Understanding the Impact of SARS-CoV-2 on Lung Endothelial Cells: Brief Mechanisms Unveiled

Fahad Hassan Shah ¹, Jun Young Bang ^1,2, Yoon Seok Nam ¹

⁰College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea.

Cell Biochemistry and Biophysics +

|

September 23, 2024

View abstract on PubMed

Summary

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes endotheliopathy, a vascular condition. This review explores the virus

Area Of Science

Vascular Biology
Virology
Immunology

Background

The COVID-19 pandemic is linked to endotheliopathy, a condition involving endothelial cell injury.
Initially, SARS-CoV-2 was thought to primarily infect respiratory epithelial cells.
Emerging evidence suggests SARS-CoV-2 also infects endothelial cells, impacting pulmonary and extrapulmonary systems.

Purpose Of The Study

To review the molecular mechanisms of SARS-CoV-2-induced endotheliopathy.
To elucidate the role of endothelial cell infection in COVID-19 complications.
To synthesize recent literature on SARS-CoV-2 and vascular dysfunction.

Main Methods

Literature review of recent studies on SARS-CoV-2 and endotheliopathy.
Analysis of autopsy findings related to vascular damage in COVID-19.
Synthesis of data on viral targeting of endothelial cells.

Main Results

SARS-CoV-2 infection can lead to endothelial cell injury and endotheliopathy.
The virus targets both pulmonary and extrapulmonary microvasculature.
Complications include thrombosis, inflammation, edema, and fibrosis due to hyperactive immune response.

Conclusions

SARS-CoV-2 plays a significant role in causing endotheliopathy beyond respiratory tissues.
Endothelial dysfunction is a key factor in severe COVID-19.
Further research is needed to fully understand the molecular pathways involved.

Keywords:

Endothelial Cells Endotheliopathy Immune Response Severe Acute Respiratory Syndrome Coronavirus 2